Selective estrogen receptor modulators and risk for coronary heart disease

Author： Cano A.   Hermenegildo C.   Oviedo P.   Tarin J. J.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.10, Iss.2, 2007-04, pp. : 97-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phytoestrogens: the ''natural'' selective estrogen receptor modulators?

By Brzezinski A.   Debi A.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 85, Iss. 1, 1999-07 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Pharmacology and clinical applications of selective estrogen receptor modulators

By Nath A.   Sitruk-Ware R.  

Climacteric, Vol. 12, Iss. 3, 2009-06 ,pp. : 188-205

Informa Healthcare

Access to resources Recommend Favorite

Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women

By de Villiers T. J.  

Climacteric, Vol. 12, Iss. 1, 2009-08 ,pp. : 108-111

Informa Healthcare

Access to resources Recommend Favorite

Urogenital effects of selective estrogen receptor modulators: a systematic review

By Albertazzi P.   Sharma S.  

Climacteric, Vol. 8, Iss. 3, 2005-09 ,pp. : 214-220

Informa Healthcare

Access to resources Recommend Favorite

Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators

By Verdier-Sevrain S.  

Climacteric, Vol. 10, Iss. 4, 2007-08 ,pp. : 289-297

Informa Healthcare

Access to resources Recommend Favorite